Results 121 to 130 of about 48,421 (285)

99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis [PDF]

open access: hybrid, 2021
Candida Cristina Quarta   +15 more
openalex   +1 more source

Age‐Dependent Differences in Canakinumab Safety: A Comprehensive Pharmacovigilance Analysis Using the FAERS Database

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang   +3 more
wiley   +1 more source

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Comprehensive Review of Types, Pathophysiology, and Treatment Approaches

open access: yesBrain and Behavior, Volume 16, Issue 5, May 2026.
Chronic inflammatory demyelinating polyneuropathy is an autoimmune disorder causing demyelination, leading to distal weakness, sensory loss, and autonomic dysfunction. Immune activation triggers macrophage‐mediated myelin damage and conduction failure.
Ayesha Khan   +11 more
wiley   +1 more source

Progressive Rapid Atherosclerotic Plaque Formation and Early Stent re‐Stenosis in an Untreated CLL Patient; A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT A 66 year‐old male with a history of hypertension and poor follow‐up for chronic lymphocytic leukemia (CLL) experienced two episodes of non‐ST elevation myocardial infarction (NSTEMI) within a 6 month period. Initial coronary angiography showed two‐vessel disease, and percutaneous coronary intervention (PCI) was performed on the left anterior ...
Mohammad Shojae   +4 more
wiley   +1 more source

AL Amyloidosis Presenting as Heart Failure: A Case Report and Review of Literature

open access: yesIndian Journal of Clinical Cardiology
Restrictive cardiomyopathy secondary to cardiac amyloidosis is an underdiagnosed cause of heart failure, and it is associated with significant morbidity and mortality.
Kumar R.   +3 more
doaj   +1 more source

Evaluation of Myocardial Stiffness in Cardiac Amyloidosis Using Acoustic Radiation Force Impulse and Natural Shear Wave Imaging [PDF]

open access: green, 2023
Felix Q. Jin   +6 more
openalex   +1 more source

Batch Size Effects on Mid‐2025 State‐of‐the‐Art Large Language Model Performance in Automated Title and Abstract Screening

open access: yesCochrane Evidence Synthesis and Methods, Volume 4, Issue 3, May 2026.
ABSTRACT Background Manual abstract screening is a primary bottleneck in evidence synthesis. Emerging evidence suggests that large language models (LLMs) can automate this task, but their performance when processing multiple references simultaneously in “batches” is uncertain.
Petter Fagerberg   +6 more
wiley   +1 more source

Four-Chamber Intracardiac Thrombi Complicating Wild-Type TTR Amyloidosis

open access: yesCase Reports in Cardiology, 2018
Cardiac amyloidosis is a rare disease, and its prevalence varies depending on the type of amyloid protein involved. Several case reports make reference to the increased risk of thrombosis and thromboembolic events in cardiac amyloidosis. We report a case
Jan M. Griffin   +4 more
doaj   +1 more source

‘Here comes the story of the Hurricane’: a case report of AL cardiac amyloidosis and myocardial bridging [PDF]

open access: gold, 2022
Luigi Cappannoli   +7 more
openalex   +1 more source

Induced Circular Dichroism From the Binding of Achiral Bivalent Ligands to Transthyretin

open access: yesJournal of Molecular Recognition, Volume 39, Issue 3, May 2026.
ABSTRACT Achiral bivalent ligands capable of simultaneous occupation of both hormone binding sites of transthyretin generate a substantial and complex induced near ultraviolet circular dichroism spectrum during protein binding, revealing the dynamics of this process.
Stephen Wood   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy